Annual Drug Patent Expirations for RECORLEV
Recorlev is a drug marketed by Strongbridge and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has twenty-eight patent family members in twenty countries.
The generic ingredient in RECORLEV is levoketoconazole. One supplier is listed for this compound. Additional details are available on the levoketoconazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
